Den Europæiske Union -
dansk -
EMA (European Medicines Agency)
fanaptum
vanda pharmaceuticals ltd - iloperidone - skizofreni - psykoleptika - behandlingen af skizofreni.
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
rosuvastatin "stada" 10 mg filmovertrukne tabletter
stada arzneimittel ag - rosuvastatin calcium - filmovertrukne tabletter - 10 mg
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
rosuvastatin "stada" 20 mg filmovertrukne tabletter
stada arzneimittel ag - rosuvastatin calcium - filmovertrukne tabletter - 20 mg
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
rosuvastatin "stada" 40 mg filmovertrukne tabletter
stada arzneimittel ag - rosuvastatin calcium - filmovertrukne tabletter - 40 mg
Den Europæiske Union -
dansk -
EMA (European Medicines Agency)
memantine accord
accord healthcare s.l.u. - memantinhydrochlorid - alzheimers sygdom - andre anti-demensmidler - behandling af patienter med moderat til svær alzheimers sygdom.
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
valsartan/hydroklortiazid "jubilant" 160 mg+12,5 mg filmovertrukne tabletter
jubilant pharmaceuticals nv - hydrochlorthiazid, valsartan - filmovertrukne tabletter - 160 mg+12,5 mg
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
memantin "orion" 10 mg filmovertrukne tabletter
orion corporation - memantinhydrochlorid - filmovertrukne tabletter - 10 mg
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
memantin "orion" 20 mg filmovertrukne tabletter
orion corporation - memantinhydrochlorid - filmovertrukne tabletter - 20 mg
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
dipentum 500 mg tabletter
2care4 aps - olsalazinnatrium - tabletter - 500 mg
Den Europæiske Union -
dansk -
EMA (European Medicines Agency)
sapropterin dipharma
dipharma arzneimittel gmbh - sapropterin dihydrochlorid - phenylketonurias - andre alimentary tract and metabolism produkter, - sapropterin dipharma is indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with phenylketonuria (pku) who have been shown to be responsive to such treatment. sapropterin dipharma is also indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with tetrahydrobiopterin (bh4) deficiency who have been shown to be responsive to such treatment.